A new prognostic strategy for gastric carcinoma: albumin level and metastatic lymph node ratio

Minerva Chir. 2014 Jun;69(3):147-53.

Abstract

Aim: We evaluated the prognostic significance of preoperative serum albumin value and metastatic lymph node ratio for gastric cancer patients.

Methods: We studied patients diagnosed with gastric carcinoma in the first Department of Surgery, Bezmialem Vakif Gureba Training and Research Hospital between January 2004 and December 2010; the patients were studied retrospectively.

Results: A total of 67 patients with a mean age of 58.7 ± 11.4 years were included in the study. The majority of patients were male (N.=53 male; N.=14 female). Most patients were in an advanced stage of the disease (stage III-IV) on admission (67.2%). We classified patients according to albumin value as "normal" Group 1 (83%) and "hypoalbuminemic" Group 2 (17%). With albumin, age, resection type, perineural invasion, and ratio of metastatic lymph nodes, T and TNM stages were significant predictors of cancer-specific survival.

Conclusion: As a result, irrespective of mechanism, pre-operative evaluations of albumin and metastatic lymph node ratio should be performed to stratify the patients for risk analysis and prognosis. A level less than 3.5 g/dL is a negative prognostic factor for resectable gastric cancers.

MeSH terms

  • Aged
  • Albumins / metabolism*
  • Biomarkers, Tumor / blood*
  • Carcinoma / blood
  • Carcinoma / diagnosis*
  • Carcinoma / mortality
  • Carcinoma / secondary*
  • Carcinoma / surgery
  • Female
  • Follow-Up Studies
  • Gastrectomy
  • Humans
  • Kaplan-Meier Estimate
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Stomach Neoplasms / blood
  • Stomach Neoplasms / diagnosis*
  • Stomach Neoplasms / mortality
  • Stomach Neoplasms / secondary*
  • Stomach Neoplasms / surgery
  • Treatment Outcome

Substances

  • Albumins
  • Biomarkers, Tumor